The report provides a detailed analysis essential for establishing a bepridil production plant. It encompasses all critical aspects necessary for bepridil production, including the cost of bepridil production, bepridil plant cost, bepridil production costs, and the overall bepridil production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a bepridil production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Bepridil is a pharmaceutical compound that is mainly used in the treatment of certain heart rhythm disorders. It is primarily prescribed to treat chronic stable angina, which is a condition where the heart does not get enough oxygen due to narrowed blood vessels. It works by affecting the movement of calcium and other ions in heart cells, which helps regulate abnormal electrical activity in the heart. It helps in relaxing the blood vessels and improving blood flow, which reduces chest pain and lowers the workload on the heart. It finds its main application in managing angina (chest pain) and some types of arrhythmias, such as atrial fibrillation, where the heartbeat becomes irregular. It is used as an antianginal and antiarrhythmic medicine in patients who do not respond well to other treatments due to its antihypertensive and selective anti-arrhythmia activities. Moreover, it is sometimes studied for its additional effects on cardiovascular function due to its unique action on multiple ion channels.
The market for bepridil is predominantly driven by its application as an antihypertensive agent for managing certain heart-related conditions, which largely promotes its demand in the medical sector. Its application as an antiarrhythmic medicine for the treatment of chronic stable angina, variant angina pectoris, and controlling irregular heartbeats or arrhythmias significantly promotes its demand in the pharmaceutical industry. Its usage as a calcium channel blocker medication to ease chest pain triggered by physical effort in patients with coronary artery disease further drives its demand in the healthcare sector.
Its demand as an anti-angina drug when other medications fail or cause issues with its ability to slow heart rate and widen blood vessels also supports its market growth. Industrial bepridil procurement is influenced by multiple factors, including the availability and pricing of raw materials, regulatory approvals for therapeutic use, and adherence to good production practices (GMP). Additionally, factors such as production efficiency, supplier qualification, environmental regulations, and streamlined distribution channels also shape the global procurement dynamics for bepridil.
Raw Material for Bepridil Production
According to the bepridil production plant project report, the major raw materials for bepridil production include 1-(3-isobutoxy-2-hydroxy)propyl pyrrolidine, thionyl chloride, and N-benzylaniline.
Production Process of Bepridil
The extensive bepridil production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of bepridil begins with the conversion of 1-(3-isobutoxy-2-hydroxy)propyl pyrrolidine into its corresponding chloro intermediate by treatment with thionyl chloride under controlled heating conditions. After completion of the reaction, the intermediate is isolated through solvent removal, aqueous workup, extraction, drying, and purification by distillation. In the next step, N-benzylaniline is activated using sodium amide in an anhydrous solvent at an elevated temperature. Further, the previously prepared chloro intermediate is added to carry out the main substitution reaction to form the bepridil base. The crude product is processed through phase separation, acid–base extraction, and further purification by distillation to obtain the pure viscous base. Finally, the pure base is converted into its hydrochloride salt using standard salt formation methods, which produces bepridil hydrochloride as the desired product.
Bepridil is a calcium channel blocker that exhibits well-characterised antianginal, antiarrhythmic, and vasodilatory properties. In its free base form, the compound is a liquid at room temperature, while its hydrochloride monohydrate salt form appears as a white-to-off-white crystalline powder with a bitter taste. The molecular formula of the compound is C24H34N2O, and its molar mass is 366.54 g/mol. Its density is approximately 1.04 g/cm³, and the compound has a boiling point of 184 degrees Celsius at 0.1 mmHg under reduced pressure. The melting point of the compound is 128 degrees Celsius. It is commercially marketed under the brand name Vascor. It is soluble in water at approximately 7.43 g/L in its free base form. Its hydrochloride salt is slightly soluble in water but very soluble in ethanol, methanol, and chloroform. The compound has a refractive index of 1.5538 at 20 degrees Celsius and should be stored at 2–8 degrees Celsius for optimal stability. It is classified as harmful if swallowed and may cause skin and eye irritation as well as respiratory irritation upon exposure. It is recommended to wear protective clothing and eye protection while handling the compound.
